BRIEF published on 05/13/2024 at 07:35, 2 years ago Covivio conserve sa notation BBB+ chez S&P avec une perspective stable Immobilier Finance Bilan Financier Notation De Crédit Marché Locatif
BRIEF published on 05/13/2024 at 07:35, 2 years ago S&P Confirms Covivio’s BBB+ Rating with Stable Outlook Real Estate Covivio Financial Stability S&P Rating BBB+ Rating
BRIEF published on 05/13/2024 at 07:23, 2 years ago All for One Group SE Reports Growth and Confirms Fiscal Year Guidance Financial Results Market Growth Dividend Approval Cloud Business SAP Solutions
BRIEF published on 05/13/2024 at 07:23, 2 years ago All for One Group SE annonce une croissance et confirme ses prévisions pour l'exercice financier Résultats Financiers La Croissance Du Marché Solutions SAP Entreprise En Nuage Approbation Du Dividende
BRIEF published on 05/13/2024 at 07:20, 2 years ago Eurofins EAG Laboratories Expands Battery Testing Capabilities Quality Improvement Battery Testing Eurofins Expansion Material Testing Innovation Acceleration
BRIEF published on 05/13/2024 at 07:20, 2 years ago Les laboratoires Eurofins EAG étendent leurs capacités de test de batteries Test De Batterie Amelioration De La Qualite Expansion D'Eurofins Tests De Matériaux Accélération De L'innovation
BRIEF published on 05/13/2024 at 07:05, 2 years ago SIG Combibloc Group AG Announces Successful €450 Million Schuldschein Placement Financial Markets Investor Demand SIG Combibloc Group AG Debt Refinancing Schuldschein
BRIEF published on 05/13/2024 at 07:05, 2 years ago SIG Combibloc Group AG annonce un placement réussi de Schuldschein de 450 millions d'euros Marchés Financiers Demande Des Investisseurs SIG Combibloc Group AG Schuldschein Refinancement De La Dette
BRIEF published on 05/13/2024 at 07:05, 2 years ago Newron Pharmaceuticals Announces Positive Results for Evenamide in Schizophrenia Study Clinical Study Schizophrenia Newron Pharmaceuticals Evenamide Mental Health Treatment
BRIEF published on 05/13/2024 at 07:05, 2 years ago Newron Pharmaceuticals annonce des résultats positifs pour l'Evenamide dans une étude sur la schizophrénie Schizophrénie Étude Clinique Produits Pharmaceutiques Newron Evenamide Traitement De Santé Mentale
Published on 05/21/2026 at 23:00, 4 hours 17 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 4 hours 17 minutes ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 4 hours 17 minutes ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/21/2026 at 22:15, 5 hours 2 minutes ago Linear Announces Acquisition, Share Consolidation and Private Placement
Published on 05/22/2026 at 03:05, 12 minutes ago BAI Capital Announces First Close of New US$800 Million Fund, Continues to Back Asia Growth and Globalization Opportunities
Published on 05/22/2026 at 02:40, 37 minutes ago ESENTIA Completes US $2 Billion Investment-Grade Bond Offering, Achieving Simultaneous Triple-Agency Rating on Inaugural Corporate Bond
Published on 05/21/2026 at 21:45, 5 hours 32 minutes ago Rendeavour becomes the African Continental Free Trade Area's inaugural implementation partner for African industrialisation and trade infrastructure
Published on 05/21/2026 at 20:10, 7 hours 7 minutes ago Ernst Russ AG Divests MV 'EF Emira' and Raises Full-Year 2026 Guidance
Published on 05/21/2026 at 20:05, 7 hours 11 minutes ago EQS-Adhoc: Ernst Russ AG: Upward revision of the guidance for the financial year 2026
Published on 05/21/2026 at 17:45, 9 hours 32 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 9 hours 32 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 16:35, 10 hours 42 minutes ago 260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026
